ReShape Lifesciences (OTCMKTS:RSLSD) vs. Bruush Oral Care (NASDAQ:BRSH) Critical Comparison

ReShape Lifesciences (OTCMKTS:RSLSDGet Free Report) and Bruush Oral Care (NASDAQ:BRSHGet Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Risk & Volatility

ReShape Lifesciences has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, Bruush Oral Care has a beta of 2.76, suggesting that its stock price is 176% more volatile than the S&P 500.

Profitability

This table compares ReShape Lifesciences and Bruush Oral Care’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ReShape Lifesciences -668.58% -163.22% -52.10%
Bruush Oral Care N/A N/A N/A

Valuation & Earnings

This table compares ReShape Lifesciences and Bruush Oral Care’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ReShape Lifesciences $610,000.00 3.12 -$81.15 million N/A N/A
Bruush Oral Care $2.92 million 0.00 N/A N/A N/A

Bruush Oral Care has higher revenue and earnings than ReShape Lifesciences.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for ReShape Lifesciences and Bruush Oral Care, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReShape Lifesciences 0 0 0 0 N/A
Bruush Oral Care 0 0 0 0 N/A

Institutional & Insider Ownership

31.9% of Bruush Oral Care shares are owned by institutional investors. 29.8% of Bruush Oral Care shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Bruush Oral Care beats ReShape Lifesciences on 7 of the 8 factors compared between the two stocks.

About ReShape Lifesciences

(Get Free Report)

ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

About Bruush Oral Care

(Get Free Report)

Bruush Oral Care Inc., an oral care company, manufactures and sells electric toothbrushes in the United States and Canada. It offers Brüush starter kit, including electric toothbrush, three brush heads, a magnetic charging stand and USB power adapter, and a travel case. It also provides brush head refills. The company sells its products through its website www.bruush.com. Bruush Oral Care Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.